Business Description
Chordate Medical Holding AB
ISIN : SE0009495559
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.56 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.4 | |||||
3-Year EBITDA Growth Rate | 21.2 | |||||
3-Year EPS without NRI Growth Rate | 22.8 | |||||
3-Year FCF Growth Rate | 24.8 | |||||
3-Year Book Growth Rate | 370.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -64.44 | |||||
12-1 Month Momentum % | 126.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.65 | |||||
Quick Ratio | 2.34 | |||||
Cash Ratio | 1.92 | |||||
Days Sales Outstanding | 81.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 82.2 | |||||
Shareholder Yield % | -77.26 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 219.13 | |||||
Operating Margin % | -2515.57 | |||||
Net Margin % | -2475.36 | |||||
FCF Margin % | -5161.87 | |||||
ROE % | -117.62 | |||||
ROA % | -94.32 | |||||
ROIC % | -218.9 | |||||
3-Year ROIIC % | 313.01 | |||||
ROC (Joel Greenblatt) % | -2805.13 | |||||
ROCE % | -117.87 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 14.35 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 9.34 | |||||
EV-to-EBIT | -0.45 | |||||
EV-to-EBITDA | -0.49 | |||||
EV-to-Revenue | 11.11 | |||||
EV-to-FCF | -0.43 | |||||
Price-to-Net-Current-Asset-Value | 9.34 | |||||
Price-to-Net-Cash | 11.68 | |||||
Earnings Yield (Greenblatt) % | -222.22 | |||||
FCF Yield % | -120.22 |